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The Ras recruitment system, a novel approach to the study of
protein–protein interactions
Yehoshua C. Broder*, Sigal Katz* and Ami Aronheim 
The yeast two-hybrid system represents one of the
most efficient approaches currently available for
identifying and characterizing protein–protein
interactions [1–4]. Although very powerful, this
procedure exhibits several problems and inherent
limitations [5]. A new system, the Sos recruitment
system (SRS), was developed recently [6] based on a
different readout from that of the two-hybrid system
[6–8]. SRS overcomes several of the limitations of the
two-hybrid system and thus serves as an attractive
alternative for studying protein–protein interactions
between known and novel proteins. Nevertheless, we
encountered a number of problems using SRS and so
have developed an improved protein recruitment
system, designated the Ras recruitment system (RRS),
based on the absolute requirement that Ras be
localized to the plasma membrane for its function
[9,10]. Ras membrane localization and activation can be
achieved through interaction between two hybrid
proteins. We have demonstrated the effectiveness of
the novel RRS system using five different known
protein–protein interactions and have identified two
previously unknown protein–protein interactions
through a library screening protocol. The first
interaction (detailed here) is between JDP2, a member
of the basic leucine zipper (bZIP) family, and C/EBPγ, a
member of the CCAAT/enhancer-binding protein
(C/EBP) family. The second interaction is between the
p21-activated protein kinase Pak65 and a small G
protein (described in the accompanying paper by
Aronheim et al. [11]). The RRS system significantly
extends the usefulness of the previously described SRS
system and overcomes several of its limitations. 
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Results and discussion
Rationale for development of the Ras recruitment system
RRS is based on the strict requirement that Ras be local-
ized to the plasma membrane for it to function [9,10]. This
localization is normally achieved via attachment of a 
farnesyl moiety to a consensus sequence in the Ras
carboxy-terminal domain known as the CAAX box [10]. In
the yeast temperature-sensitive cdc25-2 strain, the yeast
Ras (yRas) is rendered inactive at the restrictive tempera-
ture (36°C) due to lack of a functional Cdc25 guanyl
nucleotide exchange factor [7]. The expression of mam-
malian Ras lacking its CAAX box in cdc25-2 yeast is not
expected to activate the adenylyl cyclase pathway. On the
basis of this, we tested whether Ras membrane localiza-
tion can be achieved through protein–protein interaction
and result in complementation of the cdc25-2 mutation.
For this, a protein of interest (X) is fused to a cytoplasmic
Ras mutant (the ‘bait’), and a protein partner is fused to a
membrane localization signal such as a myristoylation
sequence (the ‘prey’). A protein–protein interaction
between the bait and prey would be expected to result in
Ras membrane localization and complementation of the
cdc25-2 mutation (Figure 1).
Interactions between known protein pairs
A plasmid encoding an activated Ras lacking its carboxy-
terminal CAAX box [Ras(61)∆F] was generated by PCR
and was used to fuse different bait proteins. To test the
feasibility of the RRS system, the bait plasmids were
cotransfected into cdc25-2 yeast either with an empty
expression plasmid as a control or with plasmids encoding
known protein partners and tested for their ability to com-
plement the cdc25-2 mutation. Interactions were tested
between the following proteins: the phosphatidylinositol-
3-phosphate kinase subunits p110 and p85 [12]; c-Jun and
c-Fos [13]; hSos and Grb2 [14]; Pak65 [15,16] and Src
homology 3 (SH3)-containing proteins [14,17]; and Pak65
and different Rac1 mutants [18,19] (Figure 2a–e). The
cdc25-2 yeast transformants expressing different combina-
tions of bait and prey proteins were tested for their ability
to grow at 36°C (Figure 2). In all cases tested, only trans-
formants expressing both the bait fusion and the corre-
sponding known membrane-anchored prey were able to
grow at 36°C. Negative controls, such as those expressing
the bait protein alone or with the predicted protein
partner lacking the membrane-targeting signals, were
growth arrested at 36°C. These results demonstrate that
Ras membrane localization, via protein–protein interac-
tions, is sufficient for activation of its downstream effector,
adenylyl cyclase.
RRS can be used to identify novel protein partners
We also investigated whether RRS could be used to iden-
tify previously unknown protein–protein interactions in a
screening approach. We fused Ras(61)∆F to JDP2, a
member of the bZIP family that has been shown to interact
with c-Jun and repress transcription from AP-1-dependent
reporters [6], and used the resulting fusion protein,
Ras(61)∆F–JDP2, to screen a rat pituitary cDNA expression
library fused to membrane-localization sequence [6]. About
500,000 independent transformants were screened for inter-
action with the Ras(61)∆F–JDP2 bait in the presence of a
plasmid encoding mammalian GTPase-activating protein
(GAP) [20,21]. Four clones were isolated that exhibited effi-
cient growth at 36°C only when grown under galactose-
inducing conditions, which allows a high level of expression
of the library plasmid. Plasmids derived from these yeast
clones were cotransfected with either the original bait,
Ras(61)∆F–JDP2, or a nonspecific bait, Ras(61)∆F–Pak.
Three clones interacted specifically with JDP2 and one
(clone #1) exhibited efficient growth with both baits
(Figure 3a). Sequence analysis of clone #1 showed it to
encode a Sos homologue. Membrane-bound Sos is
expected to activate the yeast Ras and represents a possible
false positive in this assay. Clone #3 did not show significant
sequence homology with known genes, but the two other
clones (#5 and #8) represented cDNA encoding C/EBPγ
[22]. To further demonstrate the association between JDP2
and C/EBPγ in vitro, we mixed reticulocyte lysates pro-
grammed with either JDP2 or members of the C/EBP
family γ and β and tested for their ability to bind a radio-
labelled Jun–TRE DNA probe in an electrophoretic mobil-
ity shift assay. While JDP2-containing lysate showed a
unique binding to the Jun–TRE sequence, the addition of
C/EBPγ lysate, surprisingly, resulted in a faster-migrating
band, in a dose-dependent manner (Figure 3b, lanes 2–6).
No such heterodimerization was observed when C/EBPβ
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Figure 1
Schematic representation of the RRS system. (a) Expression of a
cytoplasmic mammalian activated Ras (devoid of its CAAX box;
mRas(61)) fused to protein X (the ‘bait’) in cdc25-2 cells is unable to
promote cell growth at the restrictive temperature (36°C). The yeast
Ras (yRas) is present in the GDP-inactive form due to the absence of a
functional exchange factor Cdc25 at the restrictive temperature.
(b) Upon interaction between the bait protein and a membrane-
localized protein partner, Ras will be localized to the plasma membrane
and will be able to confer cell growth at the restrictive temperature.
The protein partner for the bait could be a known protein partner, a
putative protein partner (‘prey’), or a protein encoded by a cDNA in a
library screen — as shown here.
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Figure 2
Complementation of the temperature-sensitive cdc25-2 mutation
through protein–protein interactions using the RRS system. Growth is
seen for combinations of plasmids indicating (a) p110–p85
interaction, (b) Jun–Fos interaction, (c) hSos–Grb2 interaction,
(d) Pak65–Grb2 interaction, and (e) Pak65–Rac1 interaction. The
cdc25-2 cells were transformed with the indicated plasmids and
plated on glucose minimal medium supplemented with the appropriate
amino acids and bases. Four independent transformants were grown
at 25°C, replica-plated onto appropriately supplemented galactose
minimal plates and grown at the restrictive temperature, 36°C. The
shaded patches of the control transformants correspond to growth-
arrested cells. The appearance of these cells in the figure may vary due
to different exposure times. Constructs used are described in Materials
and methods; myristoylation or myristoylation-defective membrane
localization sequences are indicated by M and M* respectively. 
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was mixed with JDP2 (Figure 3b, lane 8). Neither C/EBP
alone showed binding to the Jun–TRE sequence
(Figure 3b, lanes 3,7). The binding specificity was con-
firmed using homologous Jun–TRE as a specific competitor
or a nonspecific annealed oligonucleotide (Figure 3b,
lanes 9,10). These data strongly suggest that JDP2 associ-
ates specifically with C/EBPγ and the complex formed is
able to bind the Jun–TRE sequence. The interaction
between JDP2 and C/EBPγ is the first demonstration of a
functional interaction between members of the bZIP 
and C/EBP transcription factor families. As both 
JDP2 and C/EBPγ are considered dominant-negative 
components within their family [6,23], it would be of great 
interest to explore the transcriptional role resulting from 
their association.
The data presented demonstrate that RRS is a bone fide
method for detecting interactions between known or
unknown protein partners. Although RRS can be used for
analyses of protein interactions for a wide range of pro-
teins (Figure 2), it will not be suitable for studying interac-
tions with an integral membrane protein or a protein that
interacts with a membrane component. On the other
hand, RRS can be used to map the domain responsible for
the membrane association of such a protein.
RRS combines the advantages of the SRS system with a
solution to several of its limitations. For example, protein
baits such as Pak65 (data not shown) that produce a positive
signal in the absence of an interacting partner and therefore
could not be used with the SRS system showed lower back-
ground in the RRS system and could be used to detect
protein–protein interactions. In addition, RRS efficiently
eliminates the isolation of Ras false positives (though not
Sos false positives) and therefore represents a more effi-
cient system for isolating novel interacting proteins. Finally,
the Ras protein is relatively small, thereby overcoming
several technical limitations encountered with SRS.
Materials and methods
Bait plasmids and constructs
The ADNS expression plasmid was used to express the bait proteins
under the control of the alcohol dehydrogenase constitutive promoter
[24]. For Ras plasmid (Ras(61)∆F) construction, Ras-specific oligo-
nucleotides were designed to generate a Ras fragment corresponding
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Figure 3
(a) Isolation using RRS of a previously
unknown protein–protein interaction with JDP2
as bait. The Ras(61)∆F–JDP2 bait was used to
screen a rat pituitary cDNA library in a cdc25-2
yeast strain. Four colonies exhibited efficient
growth at 36°C only when grown on medium
containing galactose. Plasmid DNA was
extracted from these colonies and reintroduced
into cdc25-2 cells with either the specific bait
Ras(61)∆F–JDP2 or a nonspecific bait,
Ras(61)∆F–Pak. Cells were grown at 25°C or
36°C. (b) Functional association between
JDP2 and C/EBPγ. Electrophoretic mobility
shift assay was used to test the association
between JDP2 and C/EBPγ. Reticulocyte
lysate was programmed with either JDP2 (JDP2
lysate is indicated by +), C/EBPγ or C/EBPβ
(indicated by γ or β). A maximal volume of 7 µl
reticulocyte lysate was used for each binding
reaction (20 µl). Unprogrammed reticulocyte
lysate was used to adjust the final lysate volume
whenever necessary. JDP2 (1 µl) lysate was
used either alone (lane 2) or with different
volumes (2, 4, 6 µl) of C/EBPγ (lanes 4,5,6,
respectively). For C/EBPβ lysate, 6 µl was used
(lanes 7,8). The indicated lysates were mixed at
room temperature for 10 min prior to the
addition of the 32P-labelled annealed Jun–TRE
oligonucleotide. Competition was performed by
addition of 50-fold excess of unlabeled
annealed oligonucleotide of either specific
competitor, Jun–TRE (sp; lane 9), or
nonspecific competitor, C/EBP/Chop annealed
oligonucleotide (ns; lane 10), together with the
32P-labelled Jun–TRE probe. The JDP2
homodimer and JDP2/C/EBPγ heterodimer 
are indicated.
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to amino acids 2–185. The RasL61 plasmid was used as a DNA tem-
plate. The Ras DNA fragment was designed to contain 5′-AAG CTT
CCC GGG ACC ATG to provide HindIII, SmaI and NcoI restriction
sites to allow amino-terminal fusion (nucleotide triplets indicate the
coding frame). The Ras carboxy-terminal end was designed to contain
either 5′-TGG ATC CTC or 5′-GGA ATT CTC to provide either a
BamHI (Yes–Ras(61)∆F-BamHI) or EcoRI (Yes–Ras(61)∆F-EcoRI)
restriction sites, respectively, to allow carboxy-terminal fusion. The fol-
lowing proteins were fused to Ras(61)∆F: p110β amino acids 31–150;
c-Jun DNA-binding domain amino acids 249–331; hSos carboxy-termi-
nal domain amino acids 1066–1333; and Pak65 regulatory domain
amino acids 3–215. The DNA fragments of p110, Jun, and hSos were
generated by PCR and fused to Ras(L61)∆F by HindIII–SmaI restric-
tion. The JDP2 cDNA fragment was fused to the Ras carboxy-terminal
domain using EcoRI–XhoI. Pak65 cDNA was fused to the Ras carboxy-
terminal domain using BamHI digestion.
Prey plasmids and constructs
All prey expression vectors are based on the Yes2 expression plasmid
(Invitrogen Ltd). pYes2 was used to express prey proteins designed
under the control of the Gal1 promoter. Yes-M, Yes-M–p85, Yes-M–Fos
are as described [6], Yes-M–Grb2 and Yes-M*–Grb2 encode full-length
Grb2 fused to either myristoylation (M) or myristoylated-defective (M*)
sequence [8]. PLCγ2 amino acids 405–1252, p85 amino acids 2–84
and mGAP amino acids 262–345 were fused to the v-Src myristoylation
signal. The Rac1 constructs used were: wild-type Rac1 (Rac1 Wt); con-
stitutively active Rac1 Q61L (Rac1 Ac); and dominant-negative Rac1
T17N (Rac1 Dn) inserted in BamHI–EcoRI sites in pYes2.
Yeast growth and manipulations
Conventional yeast transfection and manipulation protocols were used
as described [6].
Library screening
The library used has been described previously [6]. Library screening
was performed stepwise. First, plasmids encoding the bait and mGAP
[21] were cotransfected into cdc25-2 cells plated on glucose minimal
medium lacking leucine and tryptophan. Subsequently, 3 ml culture
was grown in liquid at 25°C overnight and used to inoculate 200 ml
medium for an additional 12 hr. To allow high transformation efficiency,
cells were pelleted and resuspended in 200 ml YPD medium for 3–5 hr
at 25°C prior to transfection with 20–40 µg of library plasmid DNA.
Cells were plated on about twenty 100 mm plates resulting in
5,000–10,000 transformants/plate. Transformants were incubated for
4 days at 25°C followed by replica plating onto galactose plates incu-
bated at 36°C for 2–4 days. Transformants exhibiting efficient growth
on galactose plates at 36°C were isolated and grown on glucose
minimal medium for 2 days at 25°C followed by replica plating onto
both glucose and galactose plates, incubated at 36°C.
Electrophoretic mobility shift assay
Rabbit reticulocyte lysate (TNT Quick Coupled Transcription/Transla-
tion System Promega Ltd) was used for in vitro transcription translation
of pCDNA–JDP2 (pCDNA Invitrogen Inc.), Bs–C/EBPγ and
Bs–C/EBPβ constructs were made according to the manufacturer’s
instructions. Mobility shift analysis was performed as described in [6].
The Jun–TRE oligonucleotide sequence is 5′-TTCGGGGTGACAT-
CATGGGCTAT and the C/EBP/CHOP oligonucleotide sequence is
5′-AGATCTGGCTGCAACCCCCCCTCGAGCCAGATC.
Supplementary material
A screening flow chart for RRS and diagrams of plasmids used in this
work are published with this article on the internet. 
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S1Supplementary material
Figure S1
RRS screening flow chart. Temperature-sensitive cdc25-2 yeast cells
transformed with bait and GAP expression plasmids are transfected
with a cDNA expression library plasmid. Cells are plated on glucose
minimal medium lacking tryptophan, uracyl and leucine and incubated
at the permissive temperature 25°C. Transformants are allowed to
grow for 4–5 days at 25°C before replica plating to galactose-
containing plates incubated at the restrictive temperature 36°C for
3–4 days. Clones that exhibit efficient growth at 36°C are isolated and
streaked onto a glucose-containing plate grown for an additional 2
days at 25°C. Subsequently, the isolated clones are tested for their
galactose-dependent growth at 36°C. Clones exhibiting efficient
growth on galactose-containing medium but slower growth on
glucose-containing medium are considered promising candidates and
are further analyzed. 
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Figure S2
Ras-based expression vectors. Plasmids A1–A3 are the basic vectors
used for the fusion of different bait-encoding cDNAs.
ADNS–Ras(61)∆F (A1) is an ADNS-derived plasmid [23] and is used
for fusion of baits to the amino-terminal region of Ras using the
HindIII–SmaI unique restriction sites. The following baits were fused to
A1 at the amino-terminal domain: ADNS–Jun–Ras(61)∆F (B1),
ADNS–p110–Ras(61)∆F (B2), ADNS–hSos–Ras(61)∆F (B3).
Yes–Ras(61)∆F-BamHI (A2) and Yes–Ras(61)∆F-EcoRI (A3) are
based on the commercially available Yes2 expression plasmid
(Invitrogen Inc.). These plasmids are used for fusion of baits to the
carboxy-terminal region of Ras. This can be done by first introducing
the gene of interest into the Yes2–Ras(61)∆F plasmid and then
transferring the fusion gene to ADNS by HindIII–NotI restriction (as for
plasmid B5). Alternatively, a three-fragment ligation is possible using
the Ras(61)∆F DNA fragment cut with HindIII and either EcoRI (A3) or
BamHI (A2) and the gene of interest restricted with the corresponding
5′ EcoRI or BamHI and a 3′ NotI or XhoI. The latter was performed for
plasmid B4. Note that the EcoRI frame of plasmid A3 was designed to
fit the EcoRI frame of clones derived from the library (C2). 
Figure S3
Yes2-based expression vectors. Plasmids C1–C2 are the basic
vectors for fusion of different prey-encoding cDNAs. All prey-encoding
plasmids are based on the Yes2 expression plasmid (Invitrogen Inc.).
Yes-M-polyA is used to fuse prey-encoding cDNAs using the BglII site.
In this manner, the following cDNAs were fused in frame with the v-Src
myristoylation sequence: c-Fos (D1), p85 (D2), Grb2 (D3), GAP(SH3)
(D4) and p85(SH3) (D5). Yes-M∆polyA (C2) was designed to fuse
specific cDNA or cDNA libraries to the v-Src myristoylation sequence
using the EcoRI–XhoI restriction. To do so, the BglII site in the C1
plasmid was fused with the BamHI site. This made possible the use of
the downstream restriction sites from the Yes2 polylinker. The PLCγ2
cDNA was fused in this manner (D6) as well as the rat pituitary cDNA
library. 
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